文献速递心律失常

房颤节律控制作用日益增强:JACC最新综述

The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

该综述指出房颤相关死亡率和发病率负担沉重,管理策略从关注复发转向心率控制,近期更强调通过安全有效的节律控制治疗(抗心律失常药物和/或房颤消融)减少不良心血管结局。证据日益支持对尚未长期持续的房颤患者早期节律控制,但当前临床实践和指南尚未充分反映此变化;早期节律控制可减少不可逆心房重构,预防高危患者房颤相关死亡、心衰和卒中。

要点

  • 早期节律控制可能减少不可逆心房重构,预防高危房颤患者死亡、心衰和卒中。
  • 当前指南和临床实践尚未充分反映早期节律控制的证据。
  • 节律控制治疗通常包括抗心律失常药物和/或房颤消融。

核心结论

  • 证据日益支持对尚未长期持续的房颤患者进行早期节律控制,以改善心血管结局。

研究设计与样本

  • 本文为JACC最新综述,总结房颤节律控制相关证据。

主要发现

  • 房颤相关死亡率和发病率给患者和医疗系统带来沉重负担。
  • 早期节律控制可有效减少不可逆心房重构,预防高危患者房颤相关死亡、心衰和卒中。
  • 早期节律控制有潜力阻止房颤进展,使患者免于多年症状性房颤。

临床怎么用

  • 应考虑更广泛地提供早期节律控制,尤其对尚未长期持续且高危的房颤患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a substantial burden on patients and health care services. Although the management of AF historically focused on decreasing AF recurrence, it evolved over time in favor of rate control. Recently, more emphasis has been placed on reducing adverse cardiovascular outcomes using rhythm control, generally by using safe and effective rhythm-control therapies (typically antiarrhythmic drugs and/or AF ablation). Evidence increasingly supports early rhythm control in patients with AF that has not become long-standing, but current clinical practice and guidelines do not yet fully reflect this change. Early rhythm control may effectively reduce irreversible atrial remodeling and prevent AF-related deaths, heart failure, and strokes in high-risk patients. It has the potential to halt progression and potentially save patients from years of symptomatic AF; therefore, it should be offered more widely.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Camm AJ, Naccarelli GV, Mittal S, et al. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022. PMID: 35550691. doi:10.1016/j.jacc.2022.03.337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。